DarioHealth Corp. Files 8-K: Corporate Updates
Ticker: DRIO · Form: 8-K · Filed: Sep 19, 2025 · CIK: 1533998
| Field | Detail |
|---|---|
| Company | Dariohealth CORP. (DRIO) |
| Form Type | 8-K |
| Filed Date | Sep 19, 2025 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update, financials
TL;DR
DarioHealth filed an 8-K on 9/18/25 for corporate changes & financials.
AI Summary
On September 18, 2025, DarioHealth Corp. filed an 8-K report detailing material modifications to the rights of security holders and amendments to its articles of incorporation or bylaws. The filing also includes financial statements and exhibits, indicating potential corporate restructuring or significant operational updates for the company, which is involved in surgical and medical instruments and apparatus.
Why It Matters
This 8-K filing suggests significant changes are occurring within DarioHealth Corp., potentially impacting its corporate structure, governance, or financial reporting, which investors should monitor.
Risk Assessment
Risk Level: medium — 8-K filings concerning modifications to rights and bylaws can indicate significant corporate events that may carry inherent risks.
Key Players & Entities
- DarioHealth Corp. (company) — Registrant
- September 18, 2025 (date) — Date of Earliest Event Reported
- Delaware (jurisdiction) — State of Incorporation
- 001-37704 (identifier) — Commission File Number
- 45-2973162 (identifier) — IRS Employer Identification No.
- 3841 (industry_code) — Standard Industrial Classification (SIC)
FAQ
What specific material modifications were made to the rights of DarioHealth Corp. security holders?
The filing indicates 'Material Modifications to Rights of Security Holders' as an item of disclosure, but the specific details of these modifications are not provided in the provided text snippet.
Were there any amendments to DarioHealth Corp.'s articles of incorporation or bylaws?
Yes, the filing explicitly lists 'Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year' as an item of information, suggesting such amendments occurred.
What is the significance of the 'Financial Statements and Exhibits' being included in this 8-K filing?
The inclusion of financial statements and exhibits suggests that the corporate changes or modifications being reported are accompanied by or necessitate the presentation of financial information.
When was DarioHealth Corp. incorporated, and in which state?
DarioHealth Corp. was incorporated in Delaware, as indicated by the filing.
What is the primary business of DarioHealth Corp. according to its SIC code?
According to its Standard Industrial Classification (SIC) code 3841, DarioHealth Corp. is involved in 'Surgical & Medical Instruments & Apparatus'.
Filing Stats: 1,050 words · 4 min read · ~4 pages · Grade level 13.8 · Accepted 2025-09-19 17:01:09
Key Financial Figures
- $0.0001 — registered Common Stock, par value $0.0001 per share DRIO The Nasdaq Capital M
Filing Documents
- tm2526500d1_8k.htm (8-K) — 31KB
- tm2526500d1_ex3-1.htm (EX-3.1) — 94KB
- tm2526500d1_ex3-2.htm (EX-3.2) — 108KB
- tm2526500d1_ex3-3.htm (EX-3.3) — 105KB
- tm2526500d1_ex3-4.htm (EX-3.4) — 98KB
- tm2526500d1_ex3-5.htm (EX-3.5) — 102KB
- tm2526500d1_ex3-6.htm (EX-3.6) — 100KB
- tm2526500d1_ex3-7.htm (EX-3.7) — 98KB
- 0001104659-25-091718.txt ( ) — 1070KB
- drio-20250918.xsd (EX-101.SCH) — 3KB
- drio-20250918_lab.xml (EX-101.LAB) — 33KB
- drio-20250918_pre.xml (EX-101.PRE) — 22KB
- tm2526500d1_8k_htm.xml (XML) — 4KB
03 Material Modification to Rights of Security Holders
Item 3.03 Material Modification to Rights of Security Holders. The disclosure set forth in Item 5.03 below is hereby incorporated herein by reference.
03 Amendments to Articles of Incorporation or Bylaws; Change
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On September 18, 2025, DarioHealth Corp. (the "Company"), upon obtaining the vote of a majority of the holders of the relevant classes of preferred stock and the approval of the Company's Board of Directors, filed an Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of the Company's Series A-1 Preferred Stock (the "Series A-1 Certificate of Designation"), an Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of the Company's Series C Preferred Stock (the "Series C Certificate of Designation"), an Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of the Company's Series C-2 Preferred Stock (the "Series C-2 Certificate of Designation", collectively with the Series C Certificate of Designation, the "Series C Certificates of Designation"), an Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of the Company's Series D Preferred Stock (the "Series D Certificate of Designation"), an Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of the Company's Series D-1 Preferred Stock (the "Series D-1 Certificate of Designation"), an Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of the Company's Series D-2 Preferred Stock (the "Series D-2 Certificate of Designation") and an Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of the Company's Series D-3 Preferred Stock (the "Series D-3 Certificate of Designation", collectively with the Series D Certificate of Designation, the Series D-1 Certificate of Designation and the Series D-2 Certificate of Designation, the "Series D Certificates of Designation"), all with the Secretary of State of the State of Delaware. The Series C Certificates of Designation and Series D Certificates of Designation we
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits 3.1 Second Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series A-1 Preferred Stock of DarioHealth Corp. 3.2 Second Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series C Preferred Stock of DarioHealth Corp. 3.3 Second Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series C-2 Preferred Stock of DarioHealth Corp. 3.4 Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series D Preferred Stock of DarioHealth Corp. 3.5 Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series D-1 Preferred Stock of DarioHealth Corp. 3.6 Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series D-2 Preferred Stock of DarioHealth Corp. 3.7 Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series D-3 Preferred Stock of DarioHealth Corp. 104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: September 19, 2025 DARIOHEALTH CORP. By: /s/ Chen Franco-Yehuda Name: Chen Franco-Yehuda Title: Chief Financial Officer, Treasurer, and Secretary